STRUCTURE AND FUNCTION OF FERROCHELATASE
铁螯合酶的结构和功能
基本信息
- 批准号:2190797
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-30 至 1998-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This is a Shannon Award providing partial support for the research
projects that fall short of the assigned institute's funding range but
are in the margin of excellence. The Shannon Award is intended to
provide support to test the feasibility of the approach; develop further
tests and refine research techniques; perform secondary analysis of
available data sets; or conduct discrete projects that can demonstrate
the PI's research capabilities or lend additional weight to an already
meritorious application. The abstract below is taken from the original
document submitted by the principal investigator.
Heme is essential in almost every single aspect of cell function, as it
is a required prosthetic group in proteins with very diversified
functions. Ferrochelatase (protoheme ferrolyase, EC 4.99.1.1) catalyzes
the insertion of ferrous ion into protoporphyrin IX forming the product
protoheme IX and has been recognized as a key enzyme in heme biosynthesis
since 1956. Unfortunately, for the past decades, research on
ferrochelatase has been hindered by the difficultly in obtaining
sufficient quantities of purified active enzyme, in part due to the
association of ferrochelatase with membranes and the low abundance of
ferrochelatase in mitochondria. Most of our knowledge concerning the
active sites of ferrochelatase was derived from kinetic studies of
chemically modified ferrochelatase and inhibition studies. More direct
physical investigations, such as spectroscopic studies, were not possible
due to the limited availability of purified proteins. This major hurdle
has been overcome by one of our collaborators, Dr. G. C. Ferreira, who
has successfully overexpressed the murine ferrochelatase in Escherichia
coli. Most importantly, the recombinant enzyme is associated with the
bacterial soluble fraction, facilitating the subsequent purification and
manipulation of the enzyme. We now have essentially unlimited quantities
of purified active ferrochelatase for spectroscopic and kinetic studies.
Our preliminary EPR and Mossbauer spectroscopic studies of the
recombinant enzyme reveal an important and surprising result. That is,
mammalian ferrochelatase is a metalloenzyme containing a [2Fe-2S]
cluster. These new developments have opened up many new avenues for
ferrochelatase research. We therefore propose to use a combination of
spectroscopic, chemical, biochemical, and molecular biological approaches
to investigate the structure and function of ferrochelatase. In
particular, we propose (1) to apply Mossbauer, EPR and NMR spectroscopy
to characterize and to obtain structural information about the ferrous
binding site and the [2Fe-2S] cluster, (2) to identify the amino-acid
residues essential for ferrochelatase function using site-directed
mutagenesis in combination with spectroscopic and kinetic investigations,
and (3) to elucidate the mechanism of ferrochelatase employing rapid
freeze-quench EPR and Mossbauer techniques. Since ferrochelatase uses
iron as a substrate and our preliminary results established that it is
an iron-containing enzyme, the proposed spectroscopic approach, a
combination of Mossbauer and EPR techniques, is particularly suited for
the studies of ferrochelatase. The proposed investigations are expected
to yield characteristic physical properties and structural information
concerning the substrate iron binding site and the 2[Fe-2S] clusters, and
to provide detailed mechanistic information. Possible reaction
intermediates may be trapped and characterized, and its rates of
formation and decay will be determined. the proposed studies are also
expected to shed light on the functional role of the [2Fe-2S] cluster in
ferrochelatase and provide new insights in general into the role of iron
sulfur clusters in proteins.
这是香农奖,为这项研究提供部分支持
项目低于指定研究所的资助范围,但
都处于最优秀的边缘。香农奖旨在
为测试该方法的可行性提供支持;进一步发展
测试和改进研究技术;执行二次分析
可用的数据集;或执行可演示的离散项目
PI的研究能力或为已经
值得称道的申请。以下摘要摘自原文
首席调查员提交的文件。
血红素几乎在细胞功能的每一个方面都是必不可少的,因为它
是蛋白质中一个必需的修复基团,具有非常多样化的
功能。铁络合酶(原血红素铁水解酶,EC 4.99.1.1)催化
原卟啉IX中亚铁离子的插入反应
原血红素IX,已被认为是血红素生物合成的关键酶
从1956年开始。不幸的是,在过去的几十年里,对
铁络合酶由于难以获得而受到阻碍
足够数量的纯化活性酶,部分原因是
铁络合酶与膜的结合及低丰度
线粒体中的铁络合酶。我们所知道的大部分关于
铁络合酶的活性部位是通过动力学研究得出的
化学修饰的铁络合酶及其抑制研究。更直接
物理研究,如光谱研究,是不可能的。
由于纯化蛋白的可获得性有限。这一主要障碍
已经被我们的一位合作者G.C.费雷拉博士克服了,他
已成功在大肠杆菌中过表达鼠铁络合酶
Coli.最重要的是,重组酶与
细菌可溶部分,便于后续的纯化和
对酶的操纵。我们现在基本上有无限的数量
纯化的活性铁络合酶,用于光谱和动力学研究。
我们初步的EPR和穆斯堡尔谱学研究
重组酶揭示了一个重要而令人惊讶的结果。那是,
哺乳动物铁络合酶是一种含有[2Fe-2S]的金属酶
集群。这些新的发展开辟了许多新的途径
铁络合酶研究。因此,我们建议结合使用
光谱、化学、生化和分子生物学方法
研究铁络合酶的结构和功能。在……里面
具体地说,我们建议(1)应用穆斯堡尔谱、EPR谱和核磁共振谱
以表征和获取有关铁的结构信息
结合部位和[2Fe-2S]簇,(2)鉴定氨基酸
利用定点定位技术实现铁络合酶功能所必需的残基
结合光谱和动力学研究的诱变,
(3)利用RAPID阐明铁络合酶的作用机制
冷冻淬火EPR和穆斯堡尔技术。由于络合铁酶使用
铁作为底物,我们的初步结果证实了它是
一种含铁酶,建议的光谱方法,一种
穆斯堡尔和EPR技术的结合,特别适合于
铁络合酶的研究。预计将进行拟议的调查
以获得特定的物理属性和结构信息
关于底物铁结合位置和2[Fe-2S]簇,以及
提供详细的机械信息。可能的反应
中间体可能会被捕获和表征,其速率
形成和腐烂将被确定。拟议的研究还包括
预计将阐明[2Fe-2S]团簇在
并对铁的作用提供了新的见解
蛋白质中的硫簇。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Boi-Hanh V. Huynh其他文献
Boi-Hanh V. Huynh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Boi-Hanh V. Huynh', 18)}}的其他基金
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
- 批准号:
2739253 - 财政年份:1999
- 资助金额:
$ 10万 - 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
- 批准号:
6343059 - 财政年份:1999
- 资助金额:
$ 10万 - 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
- 批准号:
6490265 - 财政年份:1999
- 资助金额:
$ 10万 - 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
- 批准号:
6138700 - 财政年份:1999
- 资助金额:
$ 10万 - 项目类别:
Biosynthesis and Novel Functions of Fe-S Clusters
Fe-S团簇的生物合成和新功能
- 批准号:
6325357 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
NOVEL REDOX PROTEINS FROM SULFATE REDUCING BACT
来自硫酸盐还原菌的新型氧化还原蛋白
- 批准号:
3306756 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
NOVEL REDOX PROTEINS FROM SULFATE REDUCING BACT
来自硫酸盐还原菌的新型氧化还原蛋白
- 批准号:
3306758 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
Biosynthesis and Novel Function of Fe-S clusters
Fe-S团簇的生物合成和新功能
- 批准号:
6918157 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
Biosynthesis and Novel Function of Fe-S clusters
Fe-S团簇的生物合成和新功能
- 批准号:
7393155 - 财政年份:1992
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Cystathionine Gamma Lyase (CSE) and Hydrogen Sulfide Regulation of Vascular Aging
胱硫醚γ裂解酶 (CSE) 和硫化氢对血管老化的调节
- 批准号:
10715408 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Development of amine-dehydrogenase and lyase biocatalysts for the sustainable manufacturing of unnatural chiral amino acids and amino alcohols
开发胺脱氢酶和裂解酶生物催化剂,用于可持续生产非天然手性氨基酸和氨基醇
- 批准号:
2870226 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Studentship
Deciphering the roles of cystathionine gamma-lyase/H2S system in Fe-S protein biogenesis and iron homeostasis
解读胱硫醚γ-裂解酶/H2S系统在Fe-S蛋白生物发生和铁稳态中的作用
- 批准号:
RGPIN-2022-05369 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Discovery Grants Program - Individual
Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signaling
胱硫醚 G-裂解酶通过气体递质硫化氢信号传导的神经保护作用
- 批准号:
10445502 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signaling
胱硫醚 G-裂解酶通过气体递质硫化氢信号传导的神经保护作用
- 批准号:
10614053 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Metabolic regulation and inhibition of ATP-citrate lyase
ATP-柠檬酸裂解酶的代谢调节和抑制
- 批准号:
10588229 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Targeting ATP-citrate lyase (ACLY) to overcome therapy resistance in breast cancer and melanoma
靶向 ATP-柠檬酸裂解酶 (ACLY) 以克服乳腺癌和黑色素瘤的治疗耐药性
- 批准号:
10580197 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
- 批准号:
10515118 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Metabolic regulation and inhibition of ATP-citrate lyase
ATP-柠檬酸裂解酶的代谢调节和抑制
- 批准号:
10444160 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
- 批准号:
10705139 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:














{{item.name}}会员




